$ABR

Insider Buying Week 05-23-25

by

The busiest week we’ve seen in some time.  In fact, it’s so busy that I would venture to say that a short-term bottom is in and there is a more room to the upside.  It’s basically all in now and I don’t often make a call like that. Name: Michael Thomas Miller Position: Executive VP & CFO Transaction Date: 05-16-2025  Shares Bought: 2,750 shares an Average Price Paid of $165.27 for Cost: $454,481 Company: Installed Building Products Inc. (IBP): Installed Building Products, Inc. primarily offers insulation installation services to residential and commercial builders across the continental United States. In addition … Read more

Insider Buying Week 11-24-23 Are Investors the Turkey this Thanksgiving?

by

Trying to read the tea leaves and glean some information from insider buying patterns is seldom obvious.  Directors are generally required to own a percentage of their board compensation in the company’s equity.  Generally is the right word because this is not a requirement at every company.  Investors viewing this information have to weigh it against past purchases, if any, actual board stock ownership requirements, the relative size of the purchase, and, of course, the recent price history.  Are they buying near the highs or, more typically, purchasing shares at recent lows in price? Insiders tend to be value buyers, … Read more

Insider Buying Picks Up Dramatically Week 8-06-21

by

For trade, details click on this link to the trades.  Name Sachs Bruce I Position: Director Shares Bought: 15,000 Average Price Paid: $197.91, Cost: $2,968,650 Company: Vertex Pharmaceuticals Inc. (VRTX) Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease – and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has … Read more